CEO Kathy Lee-Sepsick puts $50K of her own money into Femasys's $3.20/share private placement
FEMY is trading near its 52-week low of $2.291 (1.8% below the low) on elevated volume (2.5× avg).
Summary
Femasys CEO Kathy Lee-Sepsick invested $50,000 in the company's $30M private placement at $3.20 per share, demonstrating insider conviction alongside the institutional raise.
Key Events · Ownership and Investor Activity · FEMY
-
CEO Purchases $50K in Private Placement
CEO Kathy Lee-Sepsick acquired 15,625 shares at $3.20 per share for a total of $50,000, participating in the same $30M private placement announced on August 7, 2026.
-
Warrants Align CEO Incentives
Lee-Sepsick received 15,625 standard warrants (exercisable at $2.95, expiring 2029) and 15,625 milestone warrants (exercisable only after achieving $1.5M quarterly U.S. revenue and certain stock price conditions), tying her compensation to commercial milestones.
-
Insider Conviction Near 52-Week Low
The purchase at $3.20 — a premium to the current $2.25 stock price — signals strong insider confidence despite the stock trading near its 52-week low of $2.29.
-
Follows $30M Institutional Raise
This insider transaction follows the closing of a $30M private placement disclosed in an 8-K today, with the CEO's participation reinforcing the positive signal from institutional investors.
Analysis · FEMY · Industrial Applications And Services
In a powerful show of alignment, CEO Kathy Lee-Sepsick personally invested $50,000 at $3.20 per share in the same private placement that closed today, putting her own capital alongside institutional backers. She also received warrants tied to revenue and stock price milestones, directly linking her compensation to the company's commercial success. This insider participation strengthens the signal from the $30M raise, especially with the stock trading near its 52-week low.
At the time of this filing, FEMY was trading at $2.25 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.1M. The 52-week trading range was $2.29 to $22.20. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.